OLDINE DEMELIEN: Open Payments
NPI 1497106868 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 55 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $2,580 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $359 |
| Janssen Biotech, Inc. | 11 | $284 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $240 |
| Intra-Sana Laboratories | 2 | $164 |
| Lilly USA, LLC | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Vantive US Healthcare LLC | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Blueprint Medicines Corporation | 1 | $26 |
| Lucid Diagnostics Inc. | 1 | $17 |
Products named: TREMFYA, ENTYVIO, RINVOQ, RELTONE 200 MG, SKYRIZI, LINZESS, OMVOH, RELISTOR.
Industry payments across FL — which companies pay providers there.
